Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001413306-10-000001
Filing Date
2010-03-30
Accepted
2010-03-30 17:30:31
Documents
1
Period of Report
2010-03-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6089
  Complete submission text file 0001413306-10-000001.txt   8085
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address
Grais Linda S (Reporting) CIK: 0001413306 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 10714926